SE402461B - Steroidhaptener till anvendning for framstellning av antigener - Google Patents

Steroidhaptener till anvendning for framstellning av antigener

Info

Publication number
SE402461B
SE402461B SE7407108A SE7407108A SE402461B SE 402461 B SE402461 B SE 402461B SE 7407108 A SE7407108 A SE 7407108A SE 7407108 A SE7407108 A SE 7407108A SE 402461 B SE402461 B SE 402461B
Authority
SE
Sweden
Prior art keywords
haptenes
antigenes
steroid
manufacture
steroid haptenes
Prior art date
Application number
SE7407108A
Other languages
English (en)
Swedish (sv)
Other versions
SE7407108L (de
Inventor
V Torelli
A Pierdet
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of SE7407108L publication Critical patent/SE7407108L/xx
Publication of SE402461B publication Critical patent/SE402461B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE7407108A 1973-06-18 1974-05-29 Steroidhaptener till anvendning for framstellning av antigener SE402461B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7322114A FR2235949B1 (de) 1973-06-18 1973-06-18

Publications (2)

Publication Number Publication Date
SE7407108L SE7407108L (de) 1974-12-19
SE402461B true SE402461B (sv) 1978-07-03

Family

ID=9121104

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7407108A SE402461B (sv) 1973-06-18 1974-05-29 Steroidhaptener till anvendning for framstellning av antigener

Country Status (16)

Country Link
US (1) US3922292A (de)
JP (4) JPS5827280B2 (de)
AT (1) AT343295B (de)
BE (1) BE816457A (de)
BR (1) BR7404979D0 (de)
CA (1) CA1032927A (de)
DE (1) DE2429040C2 (de)
DK (1) DK322274A (de)
ES (3) ES427318A1 (de)
FR (1) FR2235949B1 (de)
GB (2) GB1478357A (de)
IE (1) IE41524B1 (de)
LU (1) LU70329A1 (de)
NL (1) NL7408041A (de)
SE (1) SE402461B (de)
ZA (1) ZA743841B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2277821A1 (fr) * 1974-07-10 1976-02-06 Roussel Uclaf Nouveaux haptenes derives de la progesterone, leur procede de preparation et leur application a la fabrication d'antigenes
FR2377417A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides substitues en 11b, ainsi que leur procede de preparation
FR2377419A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
CA1285866C (en) 1984-10-19 1991-07-09 Akiko Kubodera Immunoassay for estriol-3-sulfate
FR2665901B2 (fr) * 1989-02-24 1994-07-29 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine carbonee comportant une fonction amide, leur preparation, leur application comme medicaments.
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
DE69128820T2 (de) * 1990-08-14 1998-06-10 Hoechst Marion Roussel Inc Neue 19-Nor Steroide, die eine Amid tragende Gruppe in der 11-Beta-Stelle haben, ihre Herstellung, ihre Verwendung als Medikamente und pharmazeutische Präparate davon
JPH059418U (ja) * 1991-07-12 1993-02-09 広島アルミニウム工業株式会社 電磁コンロ用発熱器
JPH07297707A (ja) * 1994-04-27 1995-11-10 Nec Corp 位相同期発振回路
DE69737791D1 (de) 1996-04-09 2007-07-19 Univ Edinburgh Verwendung von 7-alpha-substituierten steroiden zur behandlung von neuropsychiatrischen erkrankungen
DE602005023877D1 (de) * 2004-07-27 2010-11-11 Sicor Inc Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
US7910755B2 (en) * 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3211756A (en) * 1963-07-23 1965-10-12 Searle & Co 3-hydroxyimino-17alpha-(lower alkyl)-5alpha-androstan-17beta-ols and the optionally substituted 3-acyloxyimino and 3-alkoxyimino derivatives corresponding
DE1668682A1 (de) * 1967-03-14 1971-09-23 Searle & Co Gegebenenfalls in 17-Stellung alkylierte 11,13ss-Dialkylgona-1,3,5(10)-trien-3,17ss-diole und deren Ester

Also Published As

Publication number Publication date
FR2235949B1 (de) 1978-03-17
DE2429040C2 (de) 1985-10-31
BE816457A (fr) 1974-12-17
IE41524B1 (en) 1980-01-30
IE41524L (en) 1974-12-18
DK322274A (de) 1975-02-10
BR7404979D0 (pt) 1975-01-21
US3922292A (en) 1975-11-25
LU70329A1 (de) 1975-03-06
JPS5036451A (de) 1975-04-05
GB1478356A (en) 1977-06-29
ES427318A1 (es) 1976-09-16
JPS6241719B2 (de) 1987-09-04
NL7408041A (de) 1974-12-20
DE2429040A1 (de) 1975-01-09
ATA504374A (de) 1977-09-15
JPS5934200B2 (ja) 1984-08-21
AT343295B (de) 1978-05-26
SE7407108L (de) 1974-12-19
JPS5838440B2 (ja) 1983-08-23
FR2235949A1 (de) 1975-01-31
JPS5890597A (ja) 1983-05-30
GB1478357A (en) 1977-06-29
AU7014874A (en) 1975-12-18
ZA743841B (en) 1976-01-28
ES448012A1 (es) 1977-07-01
ES448013A1 (es) 1977-07-01
CA1032927A (en) 1978-06-13
JPS5890600A (ja) 1983-05-30
JPS601200A (ja) 1985-01-07
JPS5827280B2 (ja) 1983-06-08

Similar Documents

Publication Publication Date Title
SE416527B (sv) Anordning for frammatning av festorgan
NO784144L (no) Forbindelser egnet for bruk ved fremstilling av alfa-aminobenzylpenicilliner
SE402461B (sv) Steroidhaptener till anvendning for framstellning av antigener
NO146189C (no) Anordning for fremstilling av kunst-kull-formlegemer
SE382276C (sv) Forfarande for reduktion av radioaktiva jonhartsers volym
NO138883C (no) Fremgangsmaate for fremstilling av oksiranforbindelser
SE399701B (sv) Forfarande for framstellning av hydroxyalkyldiamin
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
SE396894B (sv) Anordning for spanfri tillverkning av koniska kugghjul
NO790627L (no) Fremgangsmaate for fremstilling av hydroksyalkylxantiner
SE402451B (sv) Forfarande for framstellning av 14-desoxi-14-acetoximutilin
SE373581B (sv) Forfarande for framstellning av 2-alkylfuram-3-tioler till anvendning sasom aromatiseringsmedel
SE394436B (sv) Forfarande for framstellning av 7-halogen-linkomyciner
NO843825L (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin
SE384685B (sv) Forfarande for framstellning av linkomycinderivat
SE389105B (sv) Forfarande for framstellning av vissa angivna ketaziner
SE385011B (sv) Forfarande for framstellning av alfa-linkosaminider
SE391185B (sv) Forfarande for framstellning av eten-butadiensampolymerer
SE408418B (sv) Forfarande for framstellning av 5-fluor-pyrimidiner
SE401506B (sv) Forfarande for framstellning av bifenylyletrar
SE394668B (sv) Forfarande for framstellning av 2-etylhexan-1-al
SE380795B (sv) Forfarande for framstellning av tiokarbamider
SE411759B (sv) Forfarande for framstellning av erytromycyliminforeningar
SE382046B (sv) Forfarande for framstellning av 1-aryloxi-2-propanol
SE402905B (sv) Anordning for framstellning av dubbelrutor av helglas

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7407108-5

Effective date: 19921204

Format of ref document f/p: F